Prescription opioid use in Australian children and adolescents: a national population-based study

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Bell, Jane
dc.contributor.author	Pearson, Sallie-Anne
dc.contributor.author	Paget, Simon P
dc.contributor.author	Nielsen, Timothy
dc.contributor.author	Buckley, Nicholas A
dc.contributor.author	Collins, John
dc.contributor.author	Nassar, Natasha
dc.date.accessioned	2019-12-10
dc.date.available	2019-12-10
dc.date.issued	2019-12-10
dc.identifier.uri	https://hdl.handle.net/2123/21495
dc.description.abstract	The increased use of strong opioids should be monitored as higher doses have been associated with increased opioid-related adverse events, (such as emergency department visits, hospital admissions and deaths) and opioid use in young populations is associated with future persistent use, non-medical use, and misuse	en
dc.language.iso	en_AU	en
dc.publisher	Elsevier
dc.rights	Other	en
dc.subject	opioid use	en
dc.subject	Australian children and adolescents	en
dc.title	Prescription opioid use in Australian children and adolescents: a national population-based study	en
dc.type	Article	en
dc.identifier.doi	10.1016/S2352-4642(19)30329-3
dc.rights.other	The final version of this paper was published in: The Lancet Child and Adolescent Health 2019; 3(12): 881-8.	en
usyd.faculty	Faculty of Medicine and Health, Centre for Disability Research and Policy	en
usyd.department	Menzies Centre for Health Policy	en